Tag: ACC.21
ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use
                
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial,...            
            
        ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI
                
Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...            
            
        ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban
                
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as a...            
            
        ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients
                
Among patients with suspected acute coronary syndrome (ACS), the use of a high-sensitivity tropo...            
            
        ACC.21: Pandemic has seen burnout “double” among cardiology professionals
                
The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemi...            
            
        ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease
                
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...            
            
        ACC.21: DAPT de-escalation may benefit AMI patients
                
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...            
            
        ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman
                
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device ...            
            
        ACC.21: Apixaban not superior to standard of care following TAVI
                
Apixaban was not superior to standard of care following transcatheter aortic valve implantation ...            
            
        ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients
                Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much le...            
            
        Philips adds haemodynamic measurement to Azurion image-guided platform
                Royal Philips has announced the integration of its Interventional Hemodynamic system and portable pa...            
            
        ACC.21: Digital app should replace stent cards as a patient PCI record
                
Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...            
            
        ACC.21: App speeds up time to PCI for STEMI patients
                ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...            
            
        ACC.21 late-breaking clinical trial programme announced
                The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials...            
            
        
		













